JXSS2200027 | 帕妥珠单抗曲妥珠单抗注射液(皮下注射) | pertuzumab;trastuzumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-07-27 | | | | | view |
JXSS2200026 | 帕妥珠单抗曲妥珠单抗注射液(皮下注射) | pertuzumab;trastuzumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-07-27 | | | | | view |
JYSB2400171 | 帕妥珠曲妥珠单抗注射液(皮下注射) | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-08-03 | | Roche Pharma (Schweiz) AG | | | view |
JYSB2400139 | 帕妥珠曲妥珠单抗注射液(皮下注射) | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-06-28 | | | | | view |
JYSB2400138 | 帕妥珠曲妥珠单抗注射液(皮下注射) | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-06-28 | | Roche Pharma (Schweiz) AG | | | view |
JYSB2400170 | 帕妥珠曲妥珠单抗注射液(皮下注射) | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-08-03 | | | | | view |
CSL01011 | 曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(4) | New Drug Application | 2001-03-13 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2001-11-13 | view |
JXSS2101004 | 曲妥珠单抗注射液(皮下注射) | trastuzumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-04-21 | | | | | view |
JYSB2300111 | 曲妥珠单抗注射液(皮下注射) | trastuzumab | Injection | Biological Products | Supplementary Application | 2023-06-20 | | | | | view |
JXSS2300089 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-12-12 | | | | | view |
JYSB2400205 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products | Supplementary Application | 2024-09-11 | | | | | view |
JXSL2400217 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-11-11 | | | | | view |
JYSB2400081 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-04-08 | | | | | view |
JXSS2400013 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(3.1) | Import Drug Application | 2024-02-08 | | | | | view |
JXSL2400211 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-11-01 | | | | | view |
JXSL2400034 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-02-05 | | | | | view |
JXSS2200033 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2022-08-18 | | | | | view |
JYSB2400023 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-02-01 | | | | | view |
JXSB2400050 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-05-09 | | | | | view |
JXSB2300066 | 注射用德曲妥珠单抗(DS-8201a) | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2023-05-31 | | | | | view |